MOATAZEDI DAVID 4

What Happened

• David Moatazedi, President and Chief Executive Officer of Evolus (EOLS), received equity awards on February 17, 2026. The filing shows three grants totaling 1,397,177 award units: 313,212 restricted stock units (RSUs), 626,424 performance-based restricted stock units (PSUs, derivative), and 457,541 option-type awards (derivative). Each grant is reported with a $0 acquisition price (grant award).

Key Details

• Transaction date: 2026-02-17; Form 4 filed: 2026-02-19 (appears timely).
• Grants and reported amounts: 313,212 RSUs (F1); 626,424 PSUs (F2/F3); 457,541 option-style awards (F4). Total = 1,397,177 units.
• Reported acquisition price: $0.00 for all grants (standard for reported awards/grants).
• Vesting/terms:
  • RSUs vest in four equal annual installments beginning Feb 17, 2026, subject to continued service and certain acceleration events (F1).
  • PSUs can pay up to 200% of target based on pre-established financial metrics and relative total shareholder return over a three-year performance period ending Dec 31, 2028; any earned PSUs vest after certification (F2/F3).
  • Option-style awards vest in four equal annual installments beginning Feb 17, 2026, subject to continued service and certain acceleration events (F4).
• Shares owned after transaction: not disclosed in the provided excerpt.
• Filing timeliness: filed two days after the transaction date; no late-filing indication in the excerpt.

Context

• These are compensation grants (award code A), not open-market purchases or sales—so they reflect executive pay, not a direct market bet by the insider. PSUs are performance-based and may pay out between 0%–200% of target depending on results; they only convert to shares if performance goals are met and certified after the performance period. Vesting schedules and potential acceleration (e.g., on certain terminations or change in control) are noted in the footnotes.